重组刺桐胰蛋白酶抑制剂a的制备及其在tPA突变体纯化中的应用
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Preparation of Recombinant ETIa and Its Application in Purification for tPA Deletion Variant (NTA)
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    将基因工程菌株E.coliBL21(DE3) pET22b-mETIa高密度发酵,用异丙基硫代-β-D-半乳糖苷(IPTG)诱导,重组刺桐胰蛋白酶抑制剂a(rETIa)蛋白在E.coli中得到较高水平表达,表达量占菌体总蛋白的40%以上.经菌体破碎、包涵体变性、复性,二步柱层析纯化得到电泳纯的rETIa蛋白.测得rETIa对t-PA突变体(NTA)的抑制平衡常数Ki为8.72×10-8 mol/L.据此利用纯化的rETIa蛋白制备rETIa-Sepharose 4B亲和层析柱.直接一步纯化NTA复性液,纯化的NTA纯度达90 %以上,收率为96.2 %,纯化倍数为13.2,比活为(565.7±71.3) U/μg.

    Abstract:

    Being cultured in high cell density, E.coliBL21(DE3) harboring plasmid PET22b-mETIa were induced by IPTG and then recombinant ETIa were highly expressed.Expressed rETIa were above 40% of total bacterial protein.After primary purification through breaking E.coli, dissolving inclusion bodies, refolding,and further purification by two-step chromatographies, rETIa of electrophoretic purtity has been obtained.Inhibitory activity of rETIa against tPA deletion variant (NTA) has been detected and inhibitory constant (Ki) was 8.72×10-8mol/L.So affinity chromatography column of rETIa-Sepharose 4B was prepared for purification of NTA.After only one-step purification with this column from refolded NTA,13.2-fold puritied NTA with the specific activity of (565.7±71.3) U/μg and above 90% of purity,have been obtained with the recovery rate of 96.2%.

    参考文献
    相似文献
    引证文献
引用本文

王新,屈贤铭,杨胜利.重组刺桐胰蛋白酶抑制剂a的制备及其在tPA突变体纯化中的应用[J].生物化学与生物物理进展,2002,29(3):420-423

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2001-09-20
  • 最后修改日期:2001-10-28
  • 接受日期:
  • 在线发布日期:
  • 出版日期:
关闭